Vistogard Approval History
FDA Approved: Yes (First approved December 11, 2015)
Brand name: Vistogard
Generic name: uridine triacetate
Dosage form: Oral Granules
Company: Wellstat Therapeutics Corporation
Treatment for: Fluorouracil Overdose and Capecitabine Overdose
Vistogard (uridine triacetate) is a pyrimidine analog indicated for the emergency treatment of adults and children who receive an overdose of the cancer treatments fluorouracil or capecitabine.